Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin
Authors
Keywords
Breast cancer metastases, Tibial injection model, 4T1, Rapamycin, mTOR, Pamidronate
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 143, Issue 2, Pages 227-237
Publisher
Springer Nature
Online
2013-12-10
DOI
10.1007/s10549-013-2799-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer
- (2013) Cynthia X. Ma et al. BREAST CANCER RESEARCH AND TREATMENT
- A Phase I Trial of Sunitinib and Rapamycin in Patients with Advanced Non-Small Cell Lung Cancer
- (2013) Saiama N. Waqar et al. CHEMOTHERAPY
- Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior Chemotherapy
- (2013) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Animal models of bone cancer pain: Systematic review and meta-analyses
- (2013) Gillian L. Currie et al. PAIN
- Interventional management of cancer pain
- (2013) Arun K. Bhaskar Current Opinion in Supportive and Palliative Care
- Eicosanoids and Adipokines in Breast Cancer: From Molecular Mechanisms to Clinical Considerations
- (2012) Samar Basu et al. ANTIOXIDANTS & REDOX SIGNALING
- Pain outcomes in patients with advanced breast cancer and bone metastases
- (2012) Charles S. Cleeland et al. CANCER
- Progress in the treatment of bone metastases in cancer patients
- (2012) Malgorzata Mackiewicz-Wysocka et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The mTOR Signalling Pathway in Human Cancer
- (2012) Helena Pópulo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Spinal Cord NMDA Receptor-Mediated Activation of Mammalian Target of Rapamycin Is Required for the Development and Maintenance of Bone Cancer-Induced Pain Hypersensitivities in Rats
- (2012) Ming-Hung Shih et al. JOURNAL OF PAIN
- Tests and models of nociception and pain in rodents
- (2012) M. Barrot NEUROSCIENCE
- Immune regulation of the tumor/bone vicious cycle
- (2011) Roberta Faccio Annals of the New York Academy of Sciences
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Rapamycin inhibits osteolysis and improves survival in a model of experimental bone metastases
- (2011) Osama Hussein et al. CANCER LETTERS
- Quantifying intra-osseous growth of osteosarcoma in a murine model with radiographic analysis
- (2011) Heather A. Cole et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- P2X7 receptor-deficient mice are susceptible to bone cancer pain
- (2011) Rikke Rie Hansen et al. PAIN
- Systemic inhibition of the mammalian target of rapamycin (mTOR) pathway reduces neuropathic pain in mice
- (2011) Ilona Obara et al. PAIN
- Bone cancer pain
- (2010) Juan Miguel Jimenez-Andrade et al. Annals of the New York Academy of Sciences
- Involvement of acidic microenvironment in the pathophysiology of cancer-associated bone pain
- (2010) Toshiyuki Yoneda et al. BONE
- Addition of receptor tyrosine kinase inhibitor to radiation increases tumour control in an orthotopic murine model of breast cancer metastasis in bone
- (2008) Pawel Zwolak et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started